You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Placebo and active control dose response study of rivoglitazone in type 2 diabetics

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ocular Hypertension Trial in Rochester (Latanoprostene Bunod, Placebo)

Recruiting
  • Ocular Hypertension
  • Latanoprostene Bunod
  • Placebo
  • Rochester, Minnesota
    Bausch Site 001
Sep 29, 2022

Peri-Implantitis Trial in Badajoz (Surface decontamination procedure aiming at reconstructive therapy)

Recruiting
  • Peri-Implantitis
  • Surface decontamination procedure aiming at reconstructive therapy
  • Badajoz, Spain
    Clinica CICOM
Nov 11, 2022

Diabetes, Type 2 Trial in Kuwait City (Krill Oil, Vegetable Oil)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Krill Oil
  • Vegetable Oil
  • Kuwait City, Kuwait
    Dasman Diabetes Institute
Mar 10, 2022

Investigate Frequency of Neuronal Ceroid Lipofuxinosis Type 2

Recruiting
  • Neuronal Ceroid Lipofuxinosis Type2 (CLN2)
  • Blood Sampling
  • Adana, Turkey
  • +33 more
Nov 7, 2023

Nigella Sativa Oil as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia Trial (Nigella Sativa Oil capsule)

Not yet recruiting
  • Nigella Sativa Oil as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia
  • Nigella Sativa Oil capsule
  • (no location specified)
Jul 11, 2023

Psoriatic Arthritis, Spondylitis, Sacroilitis Trial in Germany (Tofacitinib 5 MG Oral Tablet [Xeljanz], Placebo oral tablet)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Tofacitinib 5 MG Oral Tablet [Xeljanz]
  • Placebo oral tablet
  • Berlin-Steglitz, Germany
  • +18 more
Jul 23, 2022

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial in Canada, United States (IgPro10)

Recruiting
  • Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • IgPro10
  • Phoenix, Arizona
  • +8 more
Mar 24, 2022

Ototoxicity, Drug-Induced Trial in United States (ORC-13661, Placebo)

Not yet recruiting
  • Ototoxicity, Drug-Induced
  • Denver, Colorado
  • +4 more
Feb 7, 2023

Breast Cancer Trial (Giredestrant, Abemaciclib, Inavolisib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 1, 2023

Regorafenib Plus Programmed Cell Death-1 Inhibitors in Advanced

Active, not recruiting
  • Advanced Colorectal Carcinoma
  • Beijing, China
    Department of Medical Oncology, Peking Union Medical College Hos
Feb 23, 2021

Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))

Recruiting
  • Hepatocellular Carcinoma
  • Hangzhou, Zhejiang, China
    Guoliang Shao
Aug 1, 2023

Systemic Lupus Erythematosus Trial in Worldwide (M5049 low dose, M5049 medium dose, M5049 high dose)

Recruiting
  • Systemic Lupus Erythematosus
  • M5049 low dose
  • +3 more
  • Torrance, California
  • +60 more
Aug 22, 2022

. Patients Included Will be Those Referred WithPossible

Not yet recruiting
  • Asthma
  • Biologic Agent
  • (no location specified)
Aug 31, 2023

Recruitment Trial in Toronto (Treatment rTMS, Sham rTMS)

Recruiting
  • Recruitment
  • Treatment rTMS
  • Sham rTMS
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Apr 14, 2023

Fungal Infection Trial in Ruddington ([14C]-APX001 Oral Solution, [14C]-APX001 Solution for Infusion)

Completed
  • Fungal Infection
  • [14C]-APX001 Oral Solution
  • [14C]-APX001 Solution for Infusion
  • Ruddington, Nottingham, United Kingdom
    Quotient Sciences
Sep 25, 2022

Coronary Disease Trial (Self Management Strategies)

Not yet recruiting
  • Coronary Disease
  • Self Management Strategies
  • (no location specified)
Jan 26, 2023

Diabetes Mellitus Type 1 Among Children in Egypt

Not yet recruiting
  • Diabetes Mellitus Type 1
  • +2 more
  • The Strengths and Difficulties Questionnaire (SDQ) Parent Version Parent : It consists of 25 questionnaires used to screen for behavioral problems in children aged 4-17 years.
  • (no location specified)
Jul 26, 2022

Type1 Diabetes Trial in Asheville (Aspart)

Completed
  • Type1 Diabetes Mellitus
  • Asheville, North Carolina
    Mountain Diabetes and Endocrine Center
Feb 23, 2021

Obesity Trial in Daegu, Seoul (HSG4112, Placebo)

Completed
  • Obesity
  • Daegu, Korea, Republic of
  • +1 more
Jul 27, 2022

Mesothelioma Trial run by the NCI (LMB-100, Pembrolizumab)

Terminated
Has Results
  • Mesothelioma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 3, 2021

COVID-19, Vaccine Reaction, SARS CoV 2 Infection Trial in Bamako (Ad26.COV2.S, NVX-CoV2373)

Not yet recruiting
  • COVID-19
  • +3 more
  • Ad26.COV2.S
  • NVX-CoV2373
  • Bamako, Mali
    CVD-MALI
Jun 7, 2022

Ovarian Cancer Trial (albumin-bound paclitaxel, paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Mar 31, 2022

Moderate Hepatic Impairment, Severe Hepatic Impairment, Liver Diseases Trial in Miami Lakes, Orlando (Nitazoxanide)

Completed
  • Moderate Hepatic Impairment
  • +2 more
  • Miami Lakes, Florida
  • +1 more
Oct 12, 2022

Hyperlipidemias Trial in Toronto (Teduglutide, Placebo)

Completed
  • Hyperlipidemias
  • Toronto, Ontario, Canada
  • +1 more
May 18, 2022

Nasolabial Folds Trial (No-Treatment Control, HAC 20L)

Not yet recruiting
  • Nasolabial Folds
  • No-Treatment Control
  • HAC 20L
  • (no location specified)
Aug 25, 2023